Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Herbert DuPont, MD
Bausch Health Americas, Inc.
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Santarus Investigational Site 03
Antigua Guatemala, Guatemala
- Santarus Investigational Site 14
Antigua Guatemala, Guatemala
- Santarus Investigational Site 04
Quetzaltenango, Guatemala
- Santarus Investigational Site 05
Guadalajara, Jalisco, Mexico
- Santarus Investigational Site 06
Cuernavaca, Morelos, Mexico
- Santarus Investigational Site 12
Cabo San Lucas, Mexico
- Santarus Investigational Site 10
Cancún, Mexico
- Santarus Investigational Site 07
Oaxaca City, Mexico
- Santarus Investigational Site 08
Puebla City, Mexico
- Santarus Investigational Site 09
Puerto Escondido, Mexico
- Santarus Investigational Site 11
Puerto Vallarta, Mexico
- Santarus Investigational Site 13
Tulum, Mexico
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 May 2010
- Primary completion
- 30 Jun 2012
- Completion
- 30 Jun 2012
- Last update posted
- 8 Jun 2018
- Registered enrollment
- 264
- Registry id
- NCT01142089
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.